Stay updated with breaking news from Vedanta Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microbiome Therapeutic Market to Expand at a CAGR of 31.1% and will Reach USD 1.2 Bn by 2030 Comprehensive Study by Delvens
/PRNewswire/ -- When the FDA approved Rebyota, a new class of Clostridioides Difficile (C.diff) treatment, Ferring Pharmaceuticals ushered in the first...
/PRNewswire/ -- The "Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis" report has been added to ResearchAndMarkets.com's...
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis" report has been added...
MARKET OVERVIEW Crohn’s disease is an inflammatory bowel disease (IBD) that causes digestive tract inflammation, leading to abdominal pain, severe...